Toggle navigation
Home
Search
Services
Blog
Contact
About
Warfarin Therapy Using Computer Assisted Guidance
Wurster, Mark W.
Standing Stone, Inc., Westport, CT, United States
Search grants from Mark Wurster
Search grants from Standing Stone, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Publications
Comments
Recent in Grantomics:
Massachusetts Institute of Technology
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Latiglutenase as a Treatment for Celiac Disease
Vanderbilt Center for Undiagnosed Diseases (VCUD)
AR signaling in Hormone Refractory Prostate Cancer
Physical Approach to Genetics of Cerebellum Development
Characterization of Melatonin Receptors in Brain
Recently added grants:
Immunobiology of Lung Injury and Fibrosis
Innate Immune Clearance of Host-Adapted Pulmonary Pathogens
PPAR? induces IL-6 to trigger diabetic cardiomyopathy
Intracranial pressure-mediated diffuse pathologies following traumatic brain injury
The Brain Wiring of Frontostriatal Connections in Early Psychosis
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Small Business Innovation Research Grants (SBIR) - Phase I (R43)
Project #
3R43HL069579-01S1
Application #
7871759
Study Section
Special Emphasis Panel (ZRG1-HEM-1 (10))
Program Officer
Hasan, Ahmed AK
Project Start
2009-06-15
Project End
2009-09-14
Budget Start
2009-06-15
Budget End
2009-09-14
Support Year
1
Fiscal Year
2004
Total Cost
$19,153
Indirect Cost
Institution
Name
Standing Stone, Inc.
Department
Type
DUNS #
City
Westport
State
CT
Country
United States
Zip Code
06880
Related projects
NIH 2004
R43 HL
Warfarin Therapy Using Computer Assisted Guidance
Wurster, Mark W. / Standing Stone, Inc.
$19,153
NIH 2002
R43 HL
Warfarin Therapy Using Computer Assisted Guidance
Wurster, Mark W. / Standing Stone, Inc.
$88,043
Publications
Gordon, Adam S; Fulton, Robert S; Qin, Xiang et al.
(2016)
PGRNseq: a targeted capture sequencing panel for pharmacogenetic research and implementation.
Pharmacogenet Genomics :
Comments
Be the first to comment on Mark Wurster's grant